[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-462000-105":59,"doc-detail-462000-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evaluation-of-cytocompatibility-and-anti-inflammatory-activity-of-carboxyxanthones-selected-by-in-silico-studies","Evaluation of Cytocompatibility and Anti-Inflammatory Activity of Carboxyxanthones Selected by In Silico Studies","","Carboxyxanthones bearing carboxylic acid groups attached to lipophilic aromatic rings mimic key pharmacophoric elements of many nonsteroidal anti-inflammatory drugs, making them attractive anti-inflammatory scaffolds. The study produces ten carboxyxanthones (1–10) and two intermediates (11–12) and evaluates cytocompatibility and effects on pro-inflammatory mediators interleukin-6 (IL-6) and prostaglandin E2 (PGE2). All tested compounds remain cytocompatible with LPS-stimulated macrophages. Compounds 3, 4, 7, and 8 reduce IL-6 production by ~60%. Molecular docking against cyclooxygenase-2 guides candidate selection, and carboxyxanthone 6 shows the strongest and most consistent PGE2 inhibition, comparable to celecoxib at 100 µM. Carboxyxanthones 3 and 5 show biphasic PGE2 modulation across tested concentrations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluation-of-cytocompatibility-and-anti-inflammatory-activity-of-carboxyxanthones-selected-by-in-silico-studies/462000/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluation-of-cytocompatibility-and-anti-inflammatory-activity-of-carboxyxanthones-selected-by-in-silico-studies/462000.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What anti-inflammatory targets were evaluated in the study?","Question",{"text":112,"@type":113},"The study evaluates effects on IL-6 and prostaglandin E2 (PGE2), key pro-inflammatory mediators linked to inflammatory signaling.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was cytocompatibility assessed?",{"text":117,"@type":113},"Cytocompatibility was tested in LPS-stimulated macrophages, and all compounds were reported as cytocompatible.",{"name":119,"@type":110,"acceptedAnswer":120},"Which compound showed the strongest inhibition of PGE2 in the in vitro inflammation model?",{"text":121,"@type":113},"Carboxyxanthone 6 exhibited the most potent and consistent inhibitory effect on PGE2 production and showed efficacy comparable to celecoxib at 100 µM.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},462000,1790813091,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nEvaluation of Cytocompatibility and Anti-Inflammatory Activity of Carboxyxanthones Selected by In Silico Studies  \nRicardo F. Pereira 1,†, Catarina Amoedo-Leite 1,†, Sara Gimondi 2,3, Sara F. Vieira 2,3, João Handel 1, Andreia Palmeira 1,4, Maria Elizabeth Tiritan 1,4,5,6, Madalena M. M. Pinto 1,4, Nuno M. Neves 2,3, Helena Ferreira 2,3, * and Carla Fernandes 1,4, *  \nAcademic Editors: Sung-Kun (Sean) Kim and Abby Parrill  \nReceived: 13 November 2025  \nRevised: 11 December 2025  \nAccepted: 16 December 2025  \nPublished: 22 December 2025  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira n◦ 228, 4050-313 Porto, Portugal; ricardojose.fariapereira@unifi.it (R.F.P.); catarina.leite@mcb.uu.se (C.A.-L.); up201107677@edu.ff.up.pt (J.H.); [apalmeira@ff.up.pt](apalmeira@ff.up.pt) (A.P.); [beth@ff.up.pt](beth@ff.up.pt) (M.E.T.); [madalenakijjoa@gmail.com](madalenakijjoa@gmail.com) (M.M.M.P.)  \n2 3B’s Research Group, I3BS—Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Rua Ave 1, Edifício 1 (Sede), Barco, 4805-694 Guimarães, Portugal; [sara.gimondi@i3bs.uminho.pt](sara.gimondi@i3bs.uminho.pt) (S.G.); [sara.vieira@i3bs.uminho.pt](sara.vieira@i3bs.uminho.pt) (S.F.V.);  \n[nuno@i3bs.uminho.pt](nuno@i3bs.uminho.pt) (N.M.N.)  \n3 ICVS/3B’s, PT Government Associate Laboratory, 4806-909 Braga/Guimarães, Portugal  \n4 CIIMAR/CIMAR LA, Interdisciplinary Centre of Marine and Environmental Research, Universidade do Porto, Terminal de Cruzeiros do Porto de Leixões, Avenida General Norton de Matos, s/n, 4450-208 Matosinhos, Portugal  \n5 UCIBIO, Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal  \n6 Associate Laboratory i4HB—Institute for Health and Bioeconomy, University Institute of Health Sciences—CESPU, 4585-116 Gandra, Portugal  \n* [Correspondence: helenaferreira@i3bs.uminho.pt](Correspondence: helenaferreira@i3bs.uminho.pt) (H.F.); [cfernandes@ff.up.pt](cfernandes@ff.up.pt) (C.F.)† These authors contributed equally to this work.  \nAbstract  \nCarboxyxanthones containing carboxylic acid groups linked to lipophilic aromatic rings resemble the key pharmacophoric features of many nonsteroidal anti-inflammatory drugs (NSAIDs) . This structural similarity makes them attractive scaffolds for the development of new anti-inflammatory agents. This study describes the production, cytocompatibility, and anti-inflammatory potential of ten carboxyxanthones (1–10) and two intermediates (11–12) by evaluating their effects on key pro-inflammatory mediators, namely interleukin 6 (IL-6) and prostaglandin E2 (PGE 2) . As these compounds are produced by distinct mechanisms, their multi-target potential will be evaluated. Carboxyxanthones were obtained by multi-step pathways using different synthetic approaches through classical benzophenone or diaryl ether intermediates synthesis followed by intramolecular acylation. To the best of our knowledge, the synthesis of carboxyxanthones 3 and 5 is described herein for the first time. All tested compounds were cytocompatible with lipopolysaccharide (LPS)-stimulated macrophages. The most notable carboxyxanthones were 3, 4, 7, and 8, which were able to significantly reduce IL-6 production by approximately 60% . Molecular docking simulations between compounds 1–12 and cyclooxygenase-2 were conducted to characterize the structural features underlying molecular recognition, and to identify the most promising candid","cbCaioCLn5AKUnPN","https://ap.wps.com/l/cbCaioCLn5AKUnPN","pdf",5030879,27,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What anti-inflammatory targets were evaluated in the study?\",\"answer\":\"The study evaluates effects on IL-6 and prostaglandin E2 (PGE2), key pro-inflammatory mediators linked to inflammatory signaling.\"},{\"question\":\"How was cytocompatibility assessed?\",\"answer\":\"Cytocompatibility was tested in LPS-stimulated macrophages, and all compounds were reported as cytocompatible.\"},{\"question\":\"Which compound showed the strongest inhibition of PGE2 in the in vitro inflammation model?\",\"answer\":\"Carboxyxanthone 6 exhibited the most potent and consistent inhibitory effect on PGE2 production and showed efficacy comparable to celecoxib at 100 µM.\"}]","Evaluation of Cytocompatibility and Anti-Inflammatory Activity of Carboxyxanthones Selected by In Silico Studies | PDF",1790763010,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/baa9a7e794b532cb3d93b71cd0cdfccb.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/0bd817f22874df796ce03b4478ceda79.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/dc8b73b4d4a7ed45496dfe4ef5a47d40.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/6e0acbb78c355916b1433fcd1d6f1340.webp",980,1385]